Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Michael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Neuro-Oncology
|
April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Eudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
World Neurosurgery
|
January 10, 2016
A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma
Cheng-Chia Wu, Tony J C Wang, Ashish Jani, et al.
Practical Radiation Oncology
|
March 9, 2016
Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma
Tony J C Wang, Cheng-Chia Wu, Ashish Jani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, et al.
Neuro-Oncology
|
July 9, 2018
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial
Andrew B Lassman, Martin J van den Bent, Hui K Gan, et al.
Cancer Chemotherapy and Pharmacology
|
October 28, 2017
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
Martin van den Bent, Hui K Gan, Andrew B Lassman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03
Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
The Lancet. Oncology
|
January 6, 2018
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D Ross Camidge, Eudocia Q Lee, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2021
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Michael A Vogelbaum, Paul D Brown, Hans Messersmith, et al.
Neuro-Oncology
|
April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Eudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.
World Neurosurgery
|
January 10, 2016
A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma
Cheng-Chia Wu, Tony J C Wang, Ashish Jani, et al.
Practical Radiation Oncology
|
March 9, 2016
Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma
Tony J C Wang, Cheng-Chia Wu, Ashish Jani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, et al.
Neuro-Oncology
|
July 9, 2018
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial
Andrew B Lassman, Martin J van den Bent, Hui K Gan, et al.
Cancer Chemotherapy and Pharmacology
|
October 28, 2017
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
Martin van den Bent, Hui K Gan, Andrew B Lassman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03
Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
Page
of 15